SELONSERTIB: 16 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
16
Total FAERS Reports
1 (6.3%)
Deaths Reported
14
Hospitalizations
16
As Primary/Secondary Suspect
6
Life-Threatening
First Report: 20150820 · Latest Report: 20210226
What Are the Most Common SELONSERTIB Side Effects?
#1 Most Reported
Urosepsis
6 reports (37.5%)
#2 Most Reported
Pyelonephritis
6 reports (37.5%)
#3 Most Reported
Gastrointestinal haemorrhage
6 reports (37.5%)
All SELONSERTIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Diabetes mellitus inadequate control | 6 | 37.5% | 0 | 6 |
| Gastrointestinal haemorrhage | 6 | 37.5% | 0 | 6 |
| Pyelonephritis | 6 | 37.5% | 0 | 6 |
| Urosepsis | 6 | 37.5% | 0 | 6 |
| Acute myocardial infarction | 5 | 31.3% | 0 | 5 |
Who Reports SELONSERTIB Side Effects? Age & Gender Data
Gender: 24.0% female, 76.0% male. Average age: 54.8 years. Most reports from: US. View detailed demographics →
Is SELONSERTIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2015 | 1 | 1 | 0 |
| 2018 | 6 | 0 | 6 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 4 | 0 | 4 |
What Is SELONSERTIB Used For?
| Indication | Reports |
|---|---|
| Non-alcoholic steatohepatitis | 6 |
| Diabetic nephropathy | 5 |
Official FDA Label for SELONSERTIB
Official prescribing information from the FDA-approved drug label.